Commercialized biomarkers: new horizons in prostate cancer diagnostics

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group

(2015) Ketan Badani et al.   Oncotarget

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies

(2014) F Huber et al.   BRITISH JOURNAL OF CANCER

Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registry

(2014) E. David Crawford et al.   CURRENT MEDICAL RESEARCH AND OPINION

Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies

(2014) Alan W. Partin et al.   JOURNAL OF UROLOGY

Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers

(2014) Gillian O'Hurley et al.   Molecular Oncology

Prognostic prostate tissue biomarkers of potential clinical use

(2014) Theodorus H. Van der Kwast   VIRCHOWS ARCHIV

Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer

(2013) Neal Shore et al.   CURRENT MEDICAL RESEARCH AND OPINION

Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy

(2013) Stephen J. Freedland et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort

(2013) Matthew R. Cooperberg et al.   JOURNAL OF CLINICAL ONCOLOGY

PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study

(2013) Marc C. Gittelman et al.   JOURNAL OF UROLOGY

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population

(2013) R. Jeffrey Karnes et al.   JOURNAL OF UROLOGY

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

(2013) Nicholas Erho et al.   PLoS One

The Kallikrein Panel for prostate cancer screening: Its economic impact

(2013) Jeffrey D. Voigt et al.   PROSTATE

Metabolomic signatures of aggressive prostate cancer

(2013) Jonathan E. McDunn et al.   PROSTATE

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

(2013) A E Ross et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?

(2013) Bertrand Tombal et al.   UROLOGY

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

(2012) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Patented prostate cancer biomarkers

(2012) Lisa Murphy et al.   Nature Reviews Urology

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies

(2011) Bruce J. Trock et al.   BJU INTERNATIONAL

A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening

(2011) A. J. Vickers et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection

(2011) M B Nichol et al.   PROSTATE CANCER AND PROSTATIC DISEASES

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

(2010) Amine Benchikh et al.   BMC CANCER

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

(2010) A Gupta et al.   BRITISH JOURNAL OF CANCER

A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

(2010) A. J. Vickers et al.   CLINICAL CANCER RESEARCH

Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

(2010) Flip H. Jansen et al.   EUROPEAN UROLOGY

Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication

(2010) Andrew Vickers et al.   JOURNAL OF CLINICAL ONCOLOGY

[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study

(2010) Brian V. Le et al.   JOURNAL OF UROLOGY

Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay

(2010) K Robinson et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Taking a new biomarker into routine use - A perspective from the routine clinical biochemistry laboratory

(2010) Catharine Sturgeon et al.   Proteomics Clinical Applications

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

(2008) Andrew J Vickers et al.   BMC Medicine

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study

(2008) Lori J. Sokoll et al.   JOURNAL OF UROLOGY

EAU Guidelines on Prostate Cancer

(2007) Axel Heidenreich et al.   EUROPEAN UROLOGY